Global Urology Ultrasound Machine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Urology Ultrasound Machine market size was valued at US$ 578 million in 2025 and is forecast to a readjusted size of US$ 873 million by 2032 with a CAGR of 6.0% during review period.
A urology ultrasound machine is an ultrasound imaging device configured for the examination, measurement, and image-guided treatment of the urinary and male reproductive systems. Urology ultrasound machines focus on a dedicated urology ultrasound platform, portable and handheld devices with proven urological applications, non-invasive bladder capacity scanners, and ultrasound systems for prostate imaging or biopsy guidance. These products assess the kidneys, bladder, prostate, and related anatomical structures using transabdominal, intracavitary, transrectal, transperineal, or dedicated bladder scanning probes. Core functions include B-mode and Doppler imaging, post-void residual urine measurement, bladder and prostate volume calculation, urinary tract examination, stone or obstruction assessment, biopsy guidance, and fusion image navigation.
Key Findings
Demand for residual urine measurement in the bladder remains stable.
Magnetic resonance imaging (MRI) and ultrasound fusion drive prostate biopsy.
Artificial intelligence accelerates bladder and prostate measurement.
Portable devices expand urological imaging coverage in primary care.
Mature markets grow through process upgrades.
Industry Trends
The urological ultrasound market is evolving from traditional equipment primarily focused on anatomical imaging to dedicated platforms integrating automated measurement, interventional navigation, and networked workflows. In bladder assessment, artificial intelligence and deep learning algorithms are increasingly being used for anatomical segmentation, volume calculation, and reducing manual measurement steps. Recent regulatory approvals indicate that automated bladder and prostate volume measurement is expanding from high-end trolley devices to portable and app-driven ultrasound environments. Prostate diagnostic techniques are evolving from traditional transrectal imaging to perineal guidance, MRI-ultrasound fusion, micro-ultrasound-assisted biopsy assessment, and data recording for active monitoring and focal treatment planning. The 2026 European Prostate Cancer Guidelines added indications for micro-ultrasound biopsy, demonstrating that ultrasound maintains its important technological position while MRI is deeply involved in the diagnostic pathway. Product design is also placing greater emphasis on miniaturization, rapid probe sterilization, electronic medical record connectivity, simplified user interfaces, and automated quality assistance. The long-term market will develop into a tiered product system covering routine bladder measurements, diagnostic imaging, and high-value interventional guidance.
Market Dynamics
Driven Factors
The fundamental market drivers are an aging population, the widespread presence of lower urinary tract symptoms, and the continued demand for non-invasive assessment of bladder, kidney, and prostate diseases. The aging population expands the potential patient base for benign prostatic hyperplasia, urinary retention, neurogenic bladder, and multiple coexisting chronic diseases. Healthcare systems are also increasingly prioritizing reusable diagnostic methods that do not generate ionizing radiation. Clinical guidelines recommend measuring post-void residual urine in the assessment of lower urinary tract symptoms in men; bladder ultrasound or dedicated bladder scanners can replace catheterization. Prostate diseases constitute a second stable demand base, with ultrasound used for volume assessment, biopsy guidance, and fusion localization throughout diagnosis and follow-up. Hospitals also utilize urological ultrasound to assess urinary retention and assist in catheterization decisions in emergency, postoperative, rehabilitation, and long-term care processes. These applications extend demand to urology specialties and general wards, while portable and automated systems expand the pool of healthcare personnel capable of performing standardized examinations at the patient's bedside.
Limitations: The market is limited by operator dependence, differences in clinical procedures, and functional overlap between specialized equipment and general-purpose ultrasound platforms. Patient anatomy, bladder morphology, ascites, diverticula, obesity, probe placement, and operator experience can all affect measurement results. Clinical guidelines also state that post-void residual urine values ​​alone cannot directly determine the cause of voiding dysfunction. Automated algorithms can reduce manual steps but remain an auxiliary tool; healthcare professionals bear ultimate responsibility for image quality and measurement validity. High-end prostate imaging and fusion biopsy platforms require specialized probes, software, positioning components, personnel training, and operating room integration, resulting in higher procurement and maintenance costs. Institutions with insufficient examination volume may continue to use general-purpose diagnostic ultrasound without implementing dedicated urology systems. Payment constraints, capital budgets, and long equipment replacement cycles also slow adoption in small and medium-sized institutions and resource-constrained markets. Infection control for endocavitary and transrectal probes adds costs associated with protective sheaths, sterilization, storage, and record management.
Market Opportunities: The most attractive opportunities lie in portable automation, prostate interventional guidance, and continuous or repetitive bladder monitoring. Artificial intelligence-assisted bladder and prostate measurements can shorten examination time, improve consistency, and expand the use by non-specialist ultrasound operators while maintaining clinical review. Handheld scanners connected to mobile devices are suitable for resource-constrained scenarios such as outpatient clinics, rehabilitation, home-based care, and where traditional cart-based equipment is difficult to deploy. Wearable ultrasound for periodic non-invasive bladder capacity monitoring is an emerging technology that can serve specific patients requiring repeated assessments and reduce intermittent manual scanning. MRI-ultrasound fusion, transperineal biopsy, and micro-ultrasound workflows in prostate diagnosis and treatment offer greater value because customers are purchasing not only image quality but also navigation, planning, recording, and operational standardization. Automated reporting, electronic medical record transmission, remote ultrasound support, and service models based on software upgrades or analytics also have growth potential. Suppliers capable of offering scalable product portfolios ranging from routine bladder measurements to advanced urological interventions are better positioned to enter standardized multi-departmental procurement systems in hospitals.
Industry Risks and Challenges The core challenge in the industry is ensuring reliable equipment performance across diverse patient anatomy and clinical settings while simplifying operations. Bladder scanners need to differentiate the bladder from surrounding fluid-filled structures and cover capacity measurements in adults, children, post-operative patients, and patients with complex anatomy. Prostate devices need to balance high-frequency image detail, sufficient field of view, probe ergonomics, and needle tip visibility during transrectal or transperineal procedures. Artificial intelligence functionality requires representative validation datasets, clearly defined performance boundaries, and allows clinicians to review or adjust automated results. As devices integrate with hospital networks and electronic medical records, cybersecurity, software maintenance, and data interface obligations continue to increase.
Supply Chain Analysis: The upstream of the supply chain mainly includes piezoelectric and semiconductor transducer materials, acoustic lenses, probe cables, medical-grade housings, ultrasound front-end circuits, beamformers, processors, displays, batteries, trolleys, position sensors, and biopsy guidance components. Urology-specific devices also require transrectal, transperineal, dual-plane, end-fire, abdominal, and bladder scanning probes designed according to specific frequencies, fields of view, and surgical procedures. Artificial intelligence products rely on software development tools, labeled clinical data, image processing algorithms, and secure data infrastructure. Infection control consumables, probe sleeves, biopsy needle guides, and sterilization-resistant materials constitute important repurchase links. Component value depends on acoustic performance, miniaturization, durability, electrical safety, biocompatibility, and resistance to repeated cleaning. Portable and handheld products prioritize battery life, wireless connectivity, and compact probe integration, while interventional systems require precise positioning and stable mechanical alignment.
Midstream value creation encompasses acoustic design, hardware integration, image reconstruction, urological pre-programming development, automated measurement, clinical validation, regulatory registration, and application process engineering. Dedicated bladder scanners deliver value through rapid volume calculation and simplified operation, while high-end urological platforms add value through dedicated probes, MRI-ultrasound fusion, elastography, biopsy navigation, and continuous recording. Downstream customers include hospital urology departments, imaging centers, day clinics, emergency departments, rehabilitation facilities, nursing homes, and medical device distributors. Revenue streams include equipment, probes, accessories, software licensing, maintenance, extended warranties, training, and replacement consumables. Companies with proprietary probe technology, regulatory approvals, and the ability to generate repeat purchases through services, probes, or software typically have stronger profitability. Standard portable systems face significant price competition, while dedicated interventional and fusion platforms rely more heavily on clinical evidence, installation relationships, and long-term technical support.
Market Segmentation Analysis: Non-invasive bladder volume scanners constitute a separate and high-volume device segment due to their targeted clinical function and deployment outside of specialized ultrasound departments. The core value lies in the rapid assessment of post-void residual urine without catheterization; the automated system identifies the bladder, calculates volume, and transmits the results to the clinical record. Cart-mounted devices remain important in high-frequency hospital environments, while portable and handheld products are better suited for mobility between wards and decentralized diagnostic and treatment procedures.
Dedicated diagnostic and interventional urological ultrasound systems constitute a high-value segment, supporting kidney and bladder imaging, prostate volume measurement, transrectal or transperineal biopsy, treatment guidance, and follow-up. Product differentiation depends on high-resolution B-mode, Doppler and elastography, dedicated endovascular probes, dual-plane simultaneous display, and the ability to fuse with MRI target areas. Portable diagnostic devices occupy a mid-tier segment, offering broader imaging capabilities at a lower procurement cost and higher mobility. Therefore, technological opportunities lie at one end in simplifying routine measurements and at the other in precise navigation of interventional procedures. General-purpose platforms with urological configurations compete for multi-departmental utilization, while specialized systems create value through ergonomic operation, faster surgical preparation, and comprehensive urological software.
Downstream Market Opportunities: Hospitals are the core downstream market, with imaging and bladder assessment needs across urology clinics, operating rooms, emergency departments, rehabilitation departments, and inpatient wards. Urology specialists primarily purchase prostate imaging, biopsy guidance, and long-term follow-up equipment, while emergency and post-operative departments use bladder scans to assess urinary retention and assist in catheterization decisions. Rehabilitation, spinal cord injury, and long-term care facilities present significant opportunities, as patients with neurogenic bladder and mobility disorders may require repeated monitoring of post-void residual urine. Day clinics and primary care facilities prefer portable systems with smaller footprints and simpler deployment. In emerging healthcare markets, affordable portable ultrasound and bladder scanners may expand coverage before high-end fusion biopsy platforms. Strong downstream value propositions include reduced invasive measurements, shorter examination times, standardized reporting, and integration with existing clinical records; high-end products also need to demonstrate value in biopsy localization, procedural logging, and compatibility with prostate MRI pathways.
Regional Analysis
North America and Europe are mature, high-value markets for urological ultrasound machines, with well-established urology departments, structured medical device regulatory systems, and clinical pathways supporting residual urine assessment, prostate imaging, and image-guided biopsy. North America has a strong adoption base for artificial intelligence and connected bladder measurement, with several automated bladder and prostate analysis functions recently receiving regulatory approval. Europe has a strong prostate diagnostic system, and the 2026 European guidelines further emphasize MRI-targeted and micro-ultrasound-related biopsy strategies. Customers in both regions highly value regulatory status, clinical validation, electronic health record connectivity, infection control, and full lifecycle services.
The Asia-Pacific region presents stronger long-term equipment expansion opportunities, primarily driven by an aging population, improved diagnostic accessibility, and the expansion of regional ultrasound manufacturing systems. The World Health Organization projects that by 2050, the majority of the world's elderly population will reside in low- and middle-income countries, creating a market with unevenly distributed specialty imaging resources that requires more scalable diagnostic equipment. China, Japan, and South Korea possess both medical device manufacturing capabilities and large hospital systems, while Southeast Asia offers potential for portable and cost-effective systems. Regional companies are expanding their product lines with cart-mounted, portable, and specialized probes and are gradually participating in international market competition.
Competitive Landscape: The urological ultrasound market exhibits a tiered competitive structure, with this study identifying a global pool of fifty manufacturers. Large, integrated ultrasound companies compete primarily based on their extensive installation base, universal imaging platforms, international service networks, and urological-specific probes or software. Specialized urological imaging companies differentiate themselves through high-resolution transrectal and transperineal probes, dual-plane imaging, MRI-ultrasound fusion, and surgical navigation capabilities. Specialized bladder scanner companies compete on automated volume measurement, ease of use, durability, infection control, and hospital-wide deployment. Portable and handheld device developers are lowering the spatial and operational barriers to distributed imaging applications through application platforms and AI-assisted bladder or prostate measurements. Regional manufacturers primarily compete in the routine diagnostic and portable device market based on price, local service, and flexible configuration. High-end interventional devices have significantly higher barriers to entry, requiring specialized probes, proven software, clinical cases, and long-term surgical support.
Report Scope
This report is a detailed and comprehensive analysis for global Urology Ultrasound Machine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Urology Ultrasound Machine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Urology Ultrasound Machine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Urology Ultrasound Machine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Urology Ultrasound Machine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Urology Ultrasound Machine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Urology Ultrasound Machine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare Technologies Inc., Verathon Inc., Koninklijke Philips N.V., KOELIS SAS, Exact Imaging Inc., BD, Esaote S.p.A., Laborie Medical Technologies Corp., Vitacon AS, EchoNous, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Urology Ultrasound Machine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Desktop
Cart-based
Portable
Market segment by Imaging Principle
Black and White B-mode Ultrasound
Color Doppler
Market segment by Number of Probes
≤2
≥3
Market segment by Application
Hospitals
Urology Clinics
Day Care Centers
Others
Major players covered
GE HealthCare Technologies Inc.
Verathon Inc.
Koninklijke Philips N.V.
KOELIS SAS
Exact Imaging Inc.
BD
Esaote S.p.A.
Laborie Medical Technologies Corp.
Vitacon AS
EchoNous, Inc.
Butterfly Network, Inc.
Caresono Technology Co., Ltd.
Clarius Mobile Health Corp.
MCube Technology Co., Ltd.
Suzhou PeakSonic Medical Technology Co., Ltd.
Mianyang Meike Electronic Equipment Co., Ltd.
Guangzhou Sonostar Technologies Co., Ltd.
Xuzhou Kaixin Electronic Instrument Co., Ltd.
Edgecare Inc.
Lilium Otsuka Co., Ltd.
Chengdu MEDIT Technology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Urology Ultrasound Machine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Urology Ultrasound Machine, with price, sales quantity, revenue, and global market share of Urology Ultrasound Machine from 2021 to 2026.
Chapter 3, the Urology Ultrasound Machine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Urology Ultrasound Machine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Urology Ultrasound Machine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Urology Ultrasound Machine.
Chapter 14 and 15, to describe Urology Ultrasound Machine sales channel, distributors, customers, research findings and conclusion.